IRCT20220209053979N13已完成Unknown
Bioequivalence Study of sustained release memeantin 21 mg capsule manufactured by Tasinm Pharmaceutical and Namenda 21 capsule manufactured by Forest Laboratory in 24 Healthy Volunteers under fasting condition
Tasnim Pharmaceutical0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •Healthy male or female volunteers
- •Body mass index (BMI) between 18 - 30
- •Volunteers who are willing to sign an informed consent form
排除标准
- •History of allergic reaction to memantin or formulation components
- •Taking any type of medicine in the 14 days before the start of the study
- •Participation in any type of clinical study in the last month
- •History of arrhythmia
研究者
相似试验
尚未招募
1 期
Bioequivalence of Diltiazem retardHealthy volunteersHealthy VolunteersRPCEC00000260Center for Pharmaceutical Research and Development, Havana, Cuba.24
招募中
不适用
Bioequivalence Study of Injectable Extended-Release Naltrexone (380 mg) of Nano Daru pharma Co. (Exopio®) and Vivitrol® (as a reference) in Iranian Healthy volunteersIRCT20130603013572N4ano Daru pharmaceutical Co.48
已完成
1 期
Bioequivalence Study of Torrent Pharmaceutical Limited's Venlafaxine Hydrochloride ER Capsules Under Fed ConditionsHealthyNCT01418612Torrent Pharmaceuticals Limited
已完成
1 期
Bioequivalence Study of Torrent Pharmaceutical Limited's Venlafaxine Hydrochloride ER Capsules Under Fed ConditionsHealthyNCT01418625Torrent Pharmaceuticals Limited
招募中
2 期
Bioequivalence study of two Triptorelin vials manufactured by Ronak Darou and IPSEN in patients with prostate cancerMetastatic prostate cancer.Malignant neoplasm of prostateIRCT2016090410178N10Shahid Beheshti University of Medical Sciences50